Skip to main content
Clinical Trials/EUCTR2015-000162-59-FR
EUCTR2015-000162-59-FR
Active, Not Recruiting
Phase 1

Evaluation of botulinum toxin injection efficacy in the treatment of head essential tremor by a multi-center, randomized, double–blind, parallel-group, placebo-controlled study - Btx-HT

CHU Clermont-Ferrand0 sites120 target enrollmentJune 3, 2015

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
Sponsor
CHU Clermont-Ferrand
Enrollment
120
Status
Active, Not Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 3, 2015
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
CHU Clermont-Ferrand

Eligibility Criteria

Inclusion Criteria

  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials